Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Protein based tumor necrosis factor-receptor variants for the treatment of TNF related disorders

Protein based tumor necrosis factor-receptor variants for the treatment of TNF related disorders

US Patent 7144987 · Granted Dec 5, 2006

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterodimeric antibodies that bind CD3 and tumor antigens2025
Bispecific and monospecific antibodies using novel anti-PD-1 sequences2024
Heterodimeric antibodies that bind CD3 and CD382024
Anti-PD-L1 antibodies and use thereof2024
Heterodimeric antibodies that bind CD3 and tumor antigens2024
Heterodimeric antibodies that bind CD3 and tumor antigens2024
Heterodimeric antibodies that bind CD3 and tumor antigens2023
Bispecific checkpoint inhibitor antibodies2022
Heterodimeric antibodies that bind ENPP3 and CD32022
Heterodimeric antibodies that bind CD3 and CD382022
Bispecific and monospecific antibodies using novel anti-PD-1 sequences2022
Heterodimeric antibodies that bind CD3 and tumor antigens2022